Open-channel blockers at the human α4β2 neuronal nicotinic acetylcholine receptor

Molecular Pharmacology

Volumn 53, Issue 3, 1998, Pages 555-563

  Buisson, Bruno ^a   Bertrand, Daniel ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b University Medical Center   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; ACETYLCHOLINE; AMANTADINE; DIZOCILPINE; HEXAMETHONIUM; MEMANTINE; NICOTINIC RECEPTOR;

ARTICLE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; KIDNEY CELL; MATHEMATICAL MODEL; PRIORITY JOURNAL; VOLTAGE CLAMP;

EID: 0031977071     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.3.555     Document Type: Article

References (39)

1. Adams PR (1977) Voltage jump analysis of procaine action at frog end-plate. J Physiol (Lond) 268:291-318.
2. Albuquerque EX, Eldefrawi AT, Eldefrawi ME, Mansour NA, and Tsai MC (1978) Amantadine: neuromuscular blockade by suppression of ionic conductance of the acetylcholine receptor. Science (Washington DC) 199:788-790.
3. Amador M and Dani JA (1991) MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7:207-215.
4. Ascher P, Large WA, and Rang HP (1979) Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells. J Physiol (Lond) 295:139-170.
5. Beam KG (1976) A voltage-clamp study of the effect of two lidocaine derivatives on the time course of end-plate currents. J Physiol (Lond) 258:279-300.
6. Bencherif M, Eisenhour CM, Prince RJ, Lippiello PM, and Lukas RJ (1995) The 'calcium antagonist' TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester] is a potent, noncompetitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther 275:1418-1426.
7. Bertrand D and Bader CR (1986) DATAC: a multipurpose biological data analysis program based on a mathematical interpreter, Int J Biomed Comput 18:193-202.
8. Bertrand D, Ballivet M, and Rungger D (1990) Activation and blocking of neuronal nicotinic acetylcholine receptor reconstituted in Xenopus oocytes. Proc Natl Acad Sci USA 87:1993-1997.
9. Bertrand D, Buisson B, Krause RM, Hu HY, and Bertrand S (1997) Minireview: Electrophysiology: a method to investigate the functional properties of ligandgated channels. J Recept Signal Transduct Res 17:227-242.
10. Bertrand D and Changeux JP (1995) Nicotinic receptor: an allosteric protein specialized for intercellular communication. Semin Neurosci 7:75-90.
11. Blackman JG, Ginsborg BL, and Ray C (1963) Synaptic transmission in the sympathetic ganglion of the frog. J Physiol (Lond) 167:355-373.
12. Briggs CA and McKenna DG (1996) Effect of MK-801 at the human α7 nicotinic acetylcholine receptor. Neuropharmacology 35:407-414.
13. Buisson B, Gopalakrishnan M, Arneric SP, Sullivan JP, and Bertrand D (1996) Human α4/32 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J Neurosci 16:7880-7891.
14. Charnet P, Labarca C, Cohen BN, Davidson N, Lester HA, and Pilar G (1992) Pharmacological and kinetic properties of alpha 4 beta 2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Physiol (Lond) 450:375-394.
15. Charnet P, Labarca C, Leonard RJ, Vogelaar NJ, Czyzyk L, Gouin A, Davidson N, and Lester HA (1990) An open channel blocker interacts with adjacent turns of alpha -helices in the nicotinic acetylcholine receptor. Neuron 4:87-95.
16. Chen H-SV and Lipton SA (1997) Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism. J Physiol (Lond) 499.1:27-46.
17. Chen H-SV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, and Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 12:4427-4436.
18. Clarke PBS and Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358.
19. Colquhoun D, Dreyer F, and Sheridan RE (1979) The actions of tubocurarine at the frog neuromuscular junction. J Physiol (Lond) 293:247-284.
20. Colquhoun D and Hawkes AG (1995) The principles of the stochastic interpretation of ion-channel mechanisms, in Single-Channel Recording (Sakmann B and Neher E, eds) 2nd ed, pp 397-482, Plenum Press, New York.
21. Danielczyk W (1995) Twenty-five years of amantadine therapy in Parkinson's disease. J Neural Transm 46(suppl):399-405.
22. Franke C, Hatt H, and Dudel J (1987) Liquid filament switch for ultra-fast exchanges of solutions at excised patches of synaptic membrane of crayfish muscle. Neurosci Lett 77:199-204.
23. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni-Kaplan M, Donnelly-Roberts D, Arneric SP, and Sullivan JP (1996) Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J Pharmacol Exp Ther 276:289-297.
24. Gurney AM and Rang HP (1984) The channel-blocking action of methonium compounds on the rat submandibular ganglion cells. Br J Pharmacol 82:623-642.
25. Huettner JE and Bean BP (1988) Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels. Proc Natl Acad Sci USA 85:1307-1311.
26. Kornhuber J, Quack G, Danysz W, Jellinger K, Danielczyk W, Gsell W, and Riederer P (1995) Therapeutic brain concentration of the NMDA receptor antagonist amantadine. Neuropharmacology 7:713-721.
27. Matsubayashi H, Swanson KL, and Albuquerque EX (1997) Amantadine inhibits nicotinic acetylcholine receptor function in hippocampal neurons. J Pharmacol Exp Ther 281:834-844.
28. Merlo Pich E, Pagliusi SR, Tessari M, Talabot-Ayer D, van Huijsduijnen RH, and Chiamulera C (1997) Common neural substrates for the addictive properties of nicotine and cocaine. Science (Washington DC) 275:83-86.
29. Neher E and Steinbach JH (1978) Local anaesthetics transiently block currents through single acetylcholine-receptor channels. J Physiol (Lond) 277:153-176.
30. Nisell M, Nomikos GG, and Svensson TH (1995) Nicotine dependence, midbrain dopamine systems and psychiatric disorders. Pharmacol Toxicol 76:157-162.
31. Parsons CG, Panchenko VA, Pinchenko VO, Tsyndrenko AY, and Krishtal OA (1996) Comparative patch-clamp studies with freshly dissociated rat hippocampal and striatal neurons on the NMDA receptor antagonistic effects of amantadine and memantine. Eur J Neurosci 8:446-454.
32. Paton WDM and Zaimis EJ (1951) Paralysis of autonomic ganglia by methonium salts. Br J Pharmacol Chemother 6:155-168.
33. Pontieri FE, Tanda G, Orzi F, and Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (Lond) 382:255-257.
34. Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacott S, Aronstam RS, and Albuquerque EX (1990) The anticonvulsant MK-801 interacts with the peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther 254:71-82.
35. Revah F, Bertrand D, Galzi JL, Devillers-Thiery A, Mulle C, Hussy N, Bertrand S, Ballivet M, and Changeux JP (1991) Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature (Lond) 353:846-849.
36. Tsai MC, Mansour NA, Eldefrawi AT, Eldefrawi ME, and Albuquerque EX (1978) Mechanism of action of amantadine on neuromuscular transmission. Mol Pharmacol 14:787-803.
37. Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN, and Iversen LL (1986) The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83:7104-7108.
38. Woodhull AM (1973) Ionic blockage of sodium channels in nerve. J Gen Physiol 61:687-708.
39. Zarel MM and Dani J (1995) Structural basis for explaining open-channel blockade of the NMDA receptor. J Neurosci 15:1446-1454.